Dr Teresa Leung

Northpark Private Hospital
Consulting Suite- Main Building, First Floor,
Cnr of Plenty & Greenhill Roads
Bundoora 3083
P: 03 9468 0110 | F: 03 9468 0120
E: Northpark.Consulting@healthscope.com.au

Dr Teresa Leung

MBBS FRACP FRCPA
Consultant Haematologist

Dr Teresa Leung is a general haematologist with a broad range of clinical Haematology experiences. She obtained her Bachelor of Medicine from the University of Melbourne, and undertook her haematology training at institutions including Austin Hospital, (clinical and diagnostic laboratory haematology), as well as the Royal Melbourne Hospital (clinical haematology and bone marrow transplant service).

Dr Leung is the Head of Clinical Haematology Department at Northern Health. She is also a visiting haematologist at Alfred Health. Her interest is in multiple myeloma, lymphoma and chronic lymphocytic leukaemia and their first line treatments.

Dr Leung has a passion for teaching and clinical research, and has produced several publications together with her trainees, as well as serving as a mentor for junior medical staff and medical students from University of Melbourne.

Dr Leung is pleased to see referrals on both malignant and non-malignant blood disorders, as well as provide advice on abnormal haematological investigations.

Apart from English, Dr Leung also speaks fluent Cantonese, Mandarin and Japanese.

  1. Lukito, Leung et al; Active Treatment of Selected Elderly Patients with Acute Myeloid Leukaemia Improves Survival: Results from the establishment of acute leukaemia service at the Northern Hospital; Poster Publication at Haematology Australia Association Symposium; 2016
  2. Lim, Leunget al; Venous Thromboembolism in North East Melbourne; Poster publication at Royal Australasian College of Physicians Congress; 2014
  3. Gregory, Leunget al; Rituximab is associated with improved survival for aggressive B cell CNS Lymphoma; Neuro-Oncology; 2013
  4. Leungand Turner et al; Reversible bone marrow reticulin fibrosis as a side effect of Romiplostim therapy for the treatment of chronic refractory immune thrombocytopenia. Pathology Aug 2011; 43:520-22.